The Earbud Has Become a Hearing Aid

Fact: the paperwork arrived quietly

In October 2021 the U.S. Food and Drug Administration finalized a rule creating an over-the-counter category of hearing aids, aimed at adults with perceived mild to moderate hearing loss. Sales began the following August. Bose shipped the first self-fitting OTC devices; Sony, Jabra and Sennheiser followed with their own. The rule did not merely deregulate a product; it reclassified who is allowed to sell one.

Then, in September 2024, Apple announced that its AirPods Pro 2 would gain three hearing-related functions: a clinical-grade hearing test, a hearing protection feature, and a hearing aid for mild to moderate loss. The FDA authorized the aid function the next month. Crucially, no new hardware was involved. The feature arrived as a software update to earbuds already on sale, in over 100 countries. A $249 pair of headphones became, on a Tuesday afternoon, a regulated medical device.

The United States had a nudge in this direction as early as the 2017 Over-the-Counter Hearing Aid Act, signed into law with unusual bipartisan cheerfulness. What changed in 2024 was not the law but the delivery mechanism. Hearing correction was no longer a product you purchased; it was a feature you downloaded.

Interpretation: the fitting ritual has been deleted

A hearing aid was never only an object. It was a process: an audiologist, a quiet booth, an earmold of warm silicone, weeks of return visits for adjustment. That ritual justified much of the price — devices routinely run several thousand dollars — and it also gave the device a social legitimacy. Someone in a lab coat had pronounced your ears defective and prescribed the correction.

The earbud dissolves all of it. The booth becomes a five-minute test on a phone, conducted in whatever room you happen to be sitting in, with whatever ambient noise the test app tolerates. The audiogram stops being a printout in a folder and becomes a data point in a health application, filed between step counts and resting heart rate. The fitter becomes an onboarding screen.

Two things follow. First, the stigma problem that plagued hearing aids for decades — the beige hook, the visible tube, the associated admission of age — was solved not by better industrial design but by camouflage. A white stem in an ear is a fashion accessory worn by teenagers. Nobody notices that it is also amplifying the consonants you have been missing since your twenties. Second, the company that tunes your hearing is also the company that sells you music, podcasts, and eventually whatever replaces both. It is now simultaneously the retailer, the fitter, and the equipment manufacturer. That is a concentration of roles the old model was carefully built to avoid.

Fact: the device still stops at a hard boundary

The authorization covers perceived mild to moderate sensorineural loss, self-administered by adults. The FDA continues to recommend an in-person evaluation for anyone reporting drainage, pain, sudden or asymmetric loss, or symptoms suggestive of something other than ordinary age-related decline. Those are not administrative niceties; they are the referral pathways that catch tumors and infections.

Physically, the form factor has limits too. AirPods are engineered for sessions of listening, not for the twelve to sixteen consecutive hours a traditional aid is worn, and their battery life reflects that. Deep fittings, severe to profound loss, conductive components, single-sided deafness and tinnitus protocols still require hardware and expertise that a self-fitting earbud does not offer. There is also no equivalent of a real-ear measurement — the check that verifies what is actually arriving at the eardrum rather than what the software believes it is delivering.

Interpretation: the audiologist becomes a diagnostician

The economic model of audiology was, for decades, bundled: device markup paid for the professional time around it. When the device becomes a commodity, the bundle has to be taken apart. The plausible destination is a profession that sells judgment rather than plastic — identifying pathology, treating complex and pediatric cases, managing tinnitus and balance, and handling the population whose self-test comes back ambiguous.

Some of the industry's caution about self-fitting is commercial self-interest, and some of it is genuine clinical concern. Both can be true at once. A screening tool that identifies people who would otherwise ignore a declining word-recognition score for fifteen years is a public health event, regardless of who profits from it.

Prediction: hearing will become a firmware setting

Three developments seem likely, none of them dramatic on announcement day.

Your prescription will become versioned. Traditional aids are tuned over months and then remain stable for five to seven years. Software-defined hearing will be adjusted remotely, silently, and whenever the manufacturer's update cycle demands. A hearing profile that cannot be exported becomes a reason to upgrade — and a five-year-old firmware branch will age the way mobile operating systems age. Regulators have already conceded that some software changes to a cleared device require review; expect that boundary to be renegotiated repeatedly and imperfectly.

Hearing data will become biologically interesting. An ear device that runs all day records something close to a continuous log of your acoustic life: noise exposure, speech proximity, perhaps heart rate and temperature in devices that already carry those sensors. Health apps are the polite first use. Insurers, employers and advertisers are the obvious later ones, and the export rules written for step counts were not written with hearing loss trajectories in mind.

The category will stop existing as a separate thing. Once general earbuds ship hearing test, protection and amplification features by default, the distinction between a hearing aid and a pair of headphones will become as legible to consumers as the distinction between a phone camera and a digital camera was in 2012 — which is to say, invisible. The prescription will live inside a general-purpose ear computer, and eventually inside the glasses that are already queuing up to replace the earbud.

The appliance behind your ear was a device you could be caught wearing. The earbud was one you were already wearing. That is the entire innovation, and it is not a small one.